FDA Gives Green Light For New COVID Pill

(PresidentialWire.com)- 2021 has been a fantastic year for Big Pharma, and it’s just getting better. Last Thursday, the Food and Drug Administration (FDA) announced that a second pill has been authorized to protect people against COVID-19 – this time from drug manufacturer Merck.

The new authorization is not as broad as the one granted on Wednesday for a pill developed by Pfizer. This new pill, which was developed not just by Merck but also by Ridgeback Biotherapeutics, has only been authorized for use in high-risk adults who cannot use normal treatment options already authorized by the FDA.

It means that the Merck pill can only be used if other options are too risky.

The limitation on the second pill authorization is also reflective of the fact that the new Pfizer pill has shown extremely positive results in recent trials. Effectively reducing the risk of a COVID-infected person being hospitalized or dying. The risk of hospitalization is reduced by 89% among those who take the Pfizer pill.

The new Merck pill, however, could potentially save lives among high-risk patients – which is why some 3 million courses of the pill have been ordered and will be made available in January. Some 265,000 courses of the Pfizer pill will soon be available.

Patrizia Cavazzoni, the director of the Center for Drug Evaluation and Research at the FDA, said that the new authorization “provides an additional treatment option” against COVID-19. Cavazzoni added that as new variants of the virus emerge all over the world, the range of COVID-19 therapies available must be expanded to protect people.

It just makes you think, though…why do we need all these therapies if the COVID vaccine works?